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Abstract 
Glucose-insulin system models are commonly used for identifying insulin 
sensitivity. With physiological, 2-compartment insulin kinetics models, accurate 
kinetic parameter values are required for reliable estimates of insulin sensitivity. 
This study uses data from 6 published microdialysis studies to determine the 
most appropriate parameter values for the transcapillary diffusion rate (nI) and 
cellular insulin clearance rate (nC). 
The 6 studies (12 data sets) used microdialysis techniques to simultaneously 
obtain interstitial and plasma insulin concentrations. The reported plasma 
insulin concentrations were used as input and interstitial insulin concentrations 
were simulated with the interstitial insulin kinetics sub-model. These simulated 
results were then compared to the reported interstitial measurements and the 
most appropriate set of parameter values was determined across the 12 data 
sets by combining the results. 
Interstitial insulin kinetic parameters values nI = nC = 0.0060 min-1 were shown 
to be the most appropriate. These parameter values are associated with an 
effective, interstitial insulin half-life, t½ = 58 minutes, within the range of 25-130 
minutes reported by others. 
 
1 Introduction 
Glucose-insulin system models are commonly used for identifying insulin 
sensitivity, either for glycaemic control or diagnostic purposes [1, 2]. Insulin 
sensitivity quantifies the glycaemic response to insulin. Thus, accurate kinetic 
parameter values describing the transport of insulin are necessary to obtain 
reliable estimates of insulin sensitivity. 
Insulin-mediated glucose uptake primarily occurs from the interstitial fluid. 
Insulin from plasma diffuses to the interstitial fluid surrounding tissue cells 
where it binds to cell-wall receptors, activating glucose uptake [3]. Modelling this 
behaviour with two insulin compartments is relatively common [4-7]. However, 
directly measuring the kinetic parameter values is difficult, if not impossible.  
This study determines the kinetic parameter values for a two-compartment 
physiological model with saturable clearance, using data from a number of 
published microdialysis studies. The specific model used is that described by Lin 
et al. [5], which treats the insulin kinetics parameters as population constants. 
Although this model is very similar to those described by Lotz et al. [2] and 
Pielmeier et al. [6], the published insulin kinetic parameter values are quite 
different. Hence there is a need for clarification based on physiological 
measurements. 
2 Subjects and Methods 
This study used data from 6 published studies (see Table 1) that used 
microdialysis techniques to assay interstitial insulin levels simultaneously with 
plasma insulin levels. These measurements enabled direct determination of the 
kinetic parameter values. 
2.1 Interstitial insulin kinetics model 
The interstitial insulin kinetics model used in this study was described by Lin et 
al. [5] and is shown in Equation (1) and graphically in Figure 2. Unlike many 
other models in this field, the interstitial insulin compartment in this particular 
model represents a physiological fluid space, rather than an effect compartment, 
thus permitting back-diffusion to the plasma compartment. Plasma and 
interstitial insulin concentrations are denoted I and Q, respectively. Receptor-
bound insulin saturation dynamics are characterised by a Michaelis-Menten 
function with saturation parameter αG = 1/65 l.mU-1 [5]. 




There are only two parameters that affect interstitial insulin kinetics at 
physiological concentrations. The parameter nI represents the transcapillary 
diffusion rate between the I and Q compartments. The parameter nC represents 
the irreversible cellular insulin clearance rate. Thus, only one equation is 
required, and the desired variables are separated from any other equations, data, 
or parameter values, eliminating any other potential biases. 
 
Figure 1. Schematic representation of compartmental interstitial insulin transport kinetics model.  
The transformation shown in (2) defines γ, the steady state ratio of interstitial 






The results of this study are presented in terms of nI and γ as the parameter γ 
provides a more intuitive insight than nC to the relative interstitial insulin 
concentrations at physiological levels. However, the modelling was performed 
using nC from which γ was subsequently calculated. Thus saturation and non-
steady-state effects were treated correctly. 
2.2 Microdialysis analysis 
To identify nI and γ in a direct, physiological manner, data were used from 6 
published studies (12 data sets). These studies used microdialysis to determine 
interstitial insulin concentrations. Plasma insulin concentrations were taken 
simultaneously. The 6 independent studies were conducted using infused and 
endogenous insulin at varying physiological and supra-physiological levels. Data 
used in this analysis was taken from the published reports of the studies listed in 
Table 1. 
Using reported arterial insulin concentrations (I) as input, interstitial 
concentrations (Q) were simulated with the interstitial insulin kinetics sub-
model described in (1). These simulated results were then compared to the 
reported interstitial measurements.  
A grid-search was performed over a range of nI and γ values to find the region of 
minimum error between simulated and measured interstitial insulin 
concentrations. The resolution of the grid was 0.0001 min-1 for nI and 0.01 for γ. 
For any given parameter pair, the error value was defined as the sum of absolute 
differences between the simulated and measured concentrations at the 
experimental sampling points, divided by the number of sample points (mean 
absolute error), normalised by the mean interstitial insulin level during the 
experiment. Errors across all data sets were evaluated by two methods to ensure 
robust parameter values that were not skewed by data from a single study. 
Specifically:  
I. Each error value was weighted equally, by summing error magnitude at 
each (nI, γ) pair across all data sets. 
II. Each study was weighted equally by scaling the calculated errors into the 
range [0-1] prior to summing across all data sets. 
Table 1. Published microdialysis studies used to investigate interstitial insulin kinetic parameters. N = 
number of subjects. 
Study Study Method Study Population N 
Interstitial sampling 
location 
Jansson et al. [8] 
Euglycaemic-
hyperinsulinaemic clamp 
Healthy non-obese 5 
Abdominal 
subcutaneous fat 




Body fat <=12% 
3 
Subcutaneous lymph 




Body fat 13-21% 
5 
Subcutaneous lymph 




Body fat 22-35% 
3 
Subcutaneous lymph 




Body fat >=36% 
2 
Subcutaneous lymph 
vessel; lower leg 
Sjostrand et al. [10] 
Euglycaemic-
hyperinsulinaemic clamp 
Healthy lean 10 Forearm muscle 
Euglycaemic-
hyperinsulinaemic clamp 
Healthy obese 10 Forearm muscle 




Healthy lean 10 Forearm muscle 
Herkner et al. [12] 
Oral glucose tolerance test Healthy lean 8 Mid-thigh muscle 
Euglycaemic-
hyperinsulinaemic clamp 
Healthy lean 8 Mid-thigh muscle 
Sjostrand et al. [13] 
Oral glucose tolerance test Healthy lean 10 Forearm muscle 
Oral glucose tolerance test Healthy obese 10 Forearm muscle 
It should be noted that the data from the Sjostrand et al. study [13] was 
corrected prior to use in this analysis for the labelling error present in the 
original article, as per their retraction [14]. 
2.3 Sensitivity to dynamic parameters 
The sensitivity of the results to the specific value of the parameter αG was also 
investigated. Although it is a dynamic parameter, the value of αG could 
potentially impact the observed kinetics by saturating the clearance of receptor-
bound insulin in this type of simulation. The grid-search was repeated for two 
extreme values of αG = 0 l.mU-1 and αG = 2x αG_nominal, representing conditions of 
no saturation and receptor saturation at very low insulin concentrations.  
3 Results and Discussion 
Grid-search results for the parameter optimisation using published microdialysis 
data are shown in Figure 2. The left panel shows the results from method I 
where each error value was weighted equally. The right panel shows the results 
from method II where each study was weighted equally. Data from the Herkner 
et al. [12] clamp study have been omitted as the minimum error was located at 
nI = 0, which was not physiologically reasonable. 
Figure 2 shows the regions around the minimum error points, where the 
contours enclose errors 1% and 5% greater than the minimum values. The 
parameter set, nI =0.0060 min-1, γ = 0.5 (nI = nC) is enclosed within the 5% region 
and thus provides a good compromise between the two identified minima and 
previous results, while indicating limited precision with only one significant 
figure. The choice of γ = 0.5 is consistent with that used by Lin et al. [5] and 
similar to the value of 0.6 used by Lotz et al. [2] and Pielmeier  et al. [6]. 
 
Figure 2. Grid-search error results from microdialysis analysis showing optimal parameter values. The 
left panel shows the results where each error value was weighted equally (method I), and the right 
panel shows the results where each study was weighted equally (method II). Contours are at error 1% 
and 5% greater than the minimum. Lighter areas represent lower error and darker areas, greater. 
 
Figure 3 presents the same contours as Figure 2 (shown in red) with additional 
contours for two extreme values of the saturation parameter, αG = 0 and 
2/65 l.mU-1. The nominal value used in the glucose-insulin model is 
αG = 1/65 l.mU-1. This dynamic parameter has little impact on the value of nI, as 
expected, but does cause a shift in the optimal values of nC (γ), which directly 
models insulin clearance from the receptor. The black circle indicates the 
selected parameter set. This result suggests that the identified insulin transport 
kinetic parameters are not unduly influenced by the choice of saturation 
parameter value.  
 
Figure 3. Error contours from Figure 2 (red) supplemented by two further sets of contours representing 
the impact of varying the value of αG. The black circle shows the location of the selected parameter set 
as a good compromise between the nominal value of αG and two extreme values.  
 
Table 2 shows the individual optimal parameter values for each dataset. The 
associated errors are shown along with the error obtained using the selected 
parameter set, nI =0.0060 min-1, γ = 0.5. The errors presented are unitless and 
represent the mean absolute error across the experimental sampling points for 
that study, normalised by the average interstitial insulin concentration during 
the experiment. The associated standard deviations are also shown in brackets. 
 
Table 2. Individual results from published microdialysis studies. Study minimum error is associated 
with the study optimal nI and γ. The error at the selected parameter set, nI =0.0060 min-1, γ = 0.5 is also 
shown. Errors are unitless and represent mean absolute error (standard deviation) across the 
measurement points, normalised by the average interstitial insulin concentration. Abbreviations; 












Error at selected 
(nI, γ) 
Jansson et al. 
[8] 
Clamp Healthy non-obese 0.0051 0.30 0.14 (0.15) 0.23 (0.20) 




Body fat <=12% 
0.0031 0.52 0.10 (0.09) 0.31 (0.22) 
Clamp 
Healthy:  
Body fat 13-21% 
0.0048 0.61 0.04 (0.03) 0.09 (0.07) 
Clamp 
Healthy:  
Body fat 22-35% 
0.0041 0.60 0.03 (0.03) 0.10 (0.05) 
Clamp 
Healthy:  
Body fat >=36% 
0.0041 0.42 0.04 (0.04) 0.20 (0.09) 
Sjostrand et al. 
[10] 
Clamp Healthy lean 0.0128 0.45 0.06 (0.05) 0.19 (0.12) 
Clamp Healthy obese 0.0053 0.70 0.06 (0.06) 0.07 (0.07) 
Gudbjornsdottir 
et al. [11] 
Clamp Healthy lean 0.0060 0.69 0.14 (0.18) 0.18 (0.19) 
Herkner et al. 
[12] 
OGTT Healthy lean 0.0110 0.30 0.30 (0.53) 0.46 (0.49) 
Clamp Healthy lean 0 0 0.14 (0.16) 1.55 (0.76) 
Sjostrand et al. 
[13] 
OGTT Healthy lean 0.0600 0.56 0.10 (0.15) 0.61 (0.40) 
OGTT Healthy obese 0.0500 0.44 0.06 (0.06) 0.52 (0.32) 
The optimal parameter values vary widely across the 12 data sets, particularly 
for nI. This variability could reflect the inter-patient differences, poor mixing of 
interstitial fluid, the difficulty of microdialysis techniques or lack of sensitivity to 
these parameter values. 
Figure 4 shows two contrasting examples of the simulated and measured 
interstitial insulin concentrations using the selected parameter values. Panels A 
and B show data from the Castillo study [9] for subjects with body fat in the 
range of 13-21%. Panels C and D show data from the oral glucose tolerance test 
(OGTT) study by Herkner et al. [12]. Measured arterial insulin is presented in the 
top panels (A and C), with measured and modelled interstitial insulin in the 
bottom (B and D) along with the absolute error between them. These two studies 
had similar insulin concentrations and thus make a good comparison. 
 Figure 4. Two contrasting examples from the simulation of microdialysis data using selected parameter 
set, nI =0.0060 min-1, γ = 0.5. The panels on the left show a good model fit to measured data from 
Castillo et al. [9] (body fat 13-21%). The panels on the right show a poor fit from Herkner et al. [12] 
(OGTT). The upper panels present plasma insulin concentrations and the lower panels measured and 
modelled interstitial insulin concentrations. 
 
The model fit to data is very good for the Castillo study [9] in the left panel, but 
less so for the Herkner study [12] in the right panel. The interstitial insulin peak 
at 15 minutes in the Herkner study does not correspond to any feature in the 
plasma insulin profile. The plasma insulin-sampling scheme may have missed a 
peak, the interstitial insulin peak may be spurious, or insulin may have been 
transported to the interstitium independent of plasma as the authors’ propose.  
The Herkner study was conducted using oral glucose (75 grams) to stimulate 
insulin secretion. Therefore, a sharp plasma insulin peak would not be expected 
[15], particularly within 15 minutes of glucose ingestion. The insulin kinetics 
model used for this analysis relies on passive diffusion of insulin across the 
endothelium. Hence, with no plasma insulin peak to create a sharp concentration 
gradient, the model could not reproduce the reported peak in interstitial insulin, 
resulting in the poor fit. As noted previously, data from the Herkner et al. [12] 








































































Modelled interstitial insulin profiles did not fit either data set from the Herkner 
et al. [12] study very well. The OGTT example from this study is shown in the 
right panel of Figure 4. The other data set from Herkner involved a euglycaemic-
hyperinsulinaemic clamp procedure, in which the interstitial insulin 
concentrations were lower than during the OGTT study (<10 mU/l), despite 
sustained higher plasma levels (>65 mU/l for 60 minutes). There were no 
obvious reasons for these poor fits and they may be due to the complicated and 
difficult nature of microdialysis sampling of interstitial fluid.  
The remaining studies had mean absolute error values at their individual 
optimal parameter values of less than 15% of their average interstitial insulin 
concentration. At the selected parameter set, the errors were less than 30%, 
except for the OGTT study by Sjostrand et al. [13]. The optimal nI values for these 
two datasets were very high (nI = 0.060 and 0.050 min-1, respectively), though 
similar to those used by Lotz et al. [2]. Hence, the errors for this study were large 
with the much smaller value of nI = 0.0060 min-1 selected.  
When using this insulin kinetics model and these parameter values for modelling 
insulin-mediated glucose uptake, the impact of the errors is likely to be less than 
the reported values. The values presented in Table 2 were calculated using the 
absolute value of error at each sample point, to provide a measure of goodness-
of-fit for the model. However, glucose uptake is determined by the area under 
the curve and thus the signed error values would be more appropriate to gauge 
this effect and would be equal to, or smaller than those reported. Thus, these 
values provide an upper bound on the expected model errors. 
3.1 Comparison of results 
Using direct physiological measurements from 6 published microdialysis studies, 
the most appropriate parameter values nI = 0.0060 min-1, γ = 0.5 were identified. 
The parameter value, γ = 0.5 (nI = nC) is unchanged from the value reported by 
Lin et al. [5] and similar to γ = 0.6 used by Lotz et al. [2] and Pielmeier et al. [6]. 
However, nI = 0.0060 min-1 is higher than that reported by Lin et al. [5] 
(nI = 0.0030 min-1), but considerably lower than the values,  nI =  0.0486 min-1 
and  0.0300 min-1 reported by Lotz et al. [2] and Pielmeier et al. [6], respectively.  
The value of nI identified for the ICING model by Lin et al. [5] was approximately 
16-times smaller than that used by Lotz et al. [2] for healthy and diabetic 
subjects. The result of this reduction in transcapillary diffusion (nI) and cellular 
insulin clearance rates, was that insulin persisted much longer in the interstitial 
compartment, reflecting the insulin pooling and delayed utilization effects 
observed in critically ill patients by Doran et al. [16]. 
The parameter value for nI used by Lotz et al. [2] was the transcapilliary diffusion 
rate for C-peptide identified by Van Cauter et al. [17]. This choice was justified on 
the grounds that insulin and C-peptide have similar molecular weights (5.8 kDa 
and 3.6 kDa, respectively) and passive properties. Parameter values were 
identified for each individual based on age, gender, body surface area and 
diabetic or obese status, as proposed by Van Cauter et al. The mean value 
identified across the study cohort was nI = 0.0486 min-1 [2]. The value of 
nI = 0.0300 min-1 attributed to Pielmeier et al. [6] was calculated in the same way 
as in Lotz et al. [2], but using example data presented for a single subject. 
A possible reason for the discrepancy between the values identified in this study 
and those of Lotz et al. and Pielmeier et al. is that trans-endothelial insulin 
diffusion is a saturable process [5]. The experimental diffusion rates adopted 
from Van Cauter et al. [17] are determined by using C-peptide measurements. 
Although C-peptide has very similar molecular properties to insulin, it does not 
go through a high and variable degree of first pass extraction in the portal vein 
[17]. Therefore, its concentration is several folds higher than insulin in plasma. If 
the diffusion process is to any level saturable [18], the rates determined using C-
peptide measurements would not be reflective of insulin. 
The ‘effective’ or interstitial half-life of insulin is defined by the interstitial 
kinetic parameters in (3) [5]. This half-life characterizes the clearance rate of 
insulin from the interstitium where it effects the uptake of glucose into tissue 
cells. Previously published reports suggest values in the range 25-130 minutes 
[19-21]. The range of effective half-lives for the study-specific optimal 





The effective half-life associated with the kinetic parameters identified by Lin et 
al. [5] was t½ = 116 minutes. This value better matched data from previous 
studies than the short t½ = 9 minutes used by Lotz et al. [2]. The effective half-life 
insulin determined from the selected values of nI and nC identified in this study is 
t½ = 58 minutes; this value is within the range reported by previous studies and 
is very close to the mean value for the study-specific optimal values.  
3.2 Limitations 
A significant limitation of this study is the dearth of reliable interstitial insulin 
data and the difficulty associated with obtaining it. This lack of reliable data 
necessitates population constant values for the kinetic parameters in the current 
model. If more information becomes available, the use of separate values for 
specific sub-populations could be investigated. For example, critically ill patients 
are typically sedated and their lack of movement may slow the transport 
kinetics, as the circulation and mixing of interstitial fluid is achieved by diffusion 
and the passive effects of muscle contraction and movement [22]. However, at 
present and within the framework of the glucose-insulin system model, errors 
arising from differences between the population constant kinetic parameter 
values and the actual, patient-specific values are captured by the identified 
insulin sensitivity parameter as noise. 
4 Conclusions 
This study used data from 6 published microdialysis studies to determine the 
most appropriate parameter values. Using direct physiological measurement 
data from the microdialysis studies provided a sound physiological foundation 
for the kinetic parameter values. 
The results of this investigation suggest that the most appropriate values for the 
interstitial insulin kinetic parameters for this type of model are nI = nC = 
0.0060 min-1. These parameter values are associated with an effective, 
interstitial insulin half-life t½ = 58 minutes, within the range of 25-130 minutes 
reported by others. Further, these identified insulin transport kinetic parameters 
are not unduly influenced by the value of Michaelis-Menten saturation 
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